Mitts Linked TO The Nikkei-225 Stock Average (MNL) Quote

Yes, he is crazy and dangerous. And incredibly immature.

Waiting to hear more, but more than likely taking a starter next week, I like the risk reward.

(Bloomberg) -- European Commission President Ursula von der Leyen has an idea for reducing the bloc’s consumption of Russian liquefied natural gas: import more from America.
https://www.bnnbloomberg.ca/investing/2024/11/08/eus-von-der-leyen-suggests-us-lng-could-replace-russian-supply/

“It's hard to see this pos going lower.”

It will be lower on Monday one minute after the opening bell….

There is simply no other way to see this, it is one of the two. Either Deng is fear mongering to slowly reduce the O/S on the cheap for the bigger picture down the road. Or #2, he is cancelling 50 million to create hype only to dump billions. Which one is it? That is the name of speculatio

Absolutely right. And IF that doesn't happen, I think he's unlikely to be in the Oval Office four years from now. Hello Project 2025.

Elon is seriously crazy. Did he really spend $40 billion for twitter just to get trump elected? It's just monopoly money to him. This world is so f-kd up.

A/S down to 25 bil O/S down to 7.08 bil today. OTC markets

Exactly that...

HOLY HELL!!! This body cam footage should’ve been released on day 1 exposing how Daniel Penny saved everyone on that subway!

https://x.com/Travis_4_Trump/status/1855069774943834430

History repeats. Nothing ever changes Time After Time.

[yt]VdQY7BusJNU[/yt]

"Dow tops 44,000 for first time" to join soaring S&P and QQQ.

Totally agree.

An Australian TV news interview of Ern Heaven and his wife. Ern had Alzheimer's for over 2 years and was declining when he joined the Anavex phase 2a trial of Anavex 2-73. Over a period of a year on the drug, he first stabilized, and then improved. No other drug has ever helped an Alzheimer's patien

$ILLR Top Play Next Week! The rebound from lows is underway and shorts have to pay 350% to borrow shares!
The short squeeze is on!

https://investorshub.advfn.com/uimage/uploads/2024/11/6/jqfqdblue-recent-cat.png

$ILLR Top Play Next Week! The rebound from lows is underway and shorts have to pay 350% to borrow shares!
The short squeeze is on!

https://investorshub.advfn.com/uimage/uploads/2024/11/6/jqfqdblue-recent-cat.png

I think that really would be a bridge too far. Real Wall Street people are willing to let him mess around with his crappy DJT, but I think they'll find some nice shiny objects to interest him if he tries to go beyond that.

Two acquisition will take PPS to 0.01 easily. One with $37mm revenue acquired, but not yet priced in PPS, Now we are waiting for another acquisition news be issued. So 0.01 will be reached soon. Company said: no need R/S

Told you all this was coming for over a year now. Get ready, FDA is going under the knife for a facelift. Long long long overdue.
RFK Jr. Wants To Remove Entire Departments In FDA, Tells Corrupt Employees To “Pack Your Bags”
“I can get the corruption out of the agencies,” he said.

While apres election has been free of violence, likely because the election wasn't close, there is PLENTY of latent anger at Trump, from the already mental Dems (tampons in the boys room, believing biological girls are boys, holding there are about fifty genders, etc.).
I think Trump has to

Courtesy of Chanel5:

RecoveryRX Veterinary
Finland

https://www.linkedin.com/posts/lasse-%C3%A5bb...07585-05Pt


"That's it!
Finland's first drug-free pain management device for animals, RecoveryRx Vet.

ask for more infor

Right. I agree. You can't hide the fact that people who are taking Blarcamesine are feeling better. Everybody can see it. I hope to have access to Blarcamesine next year via home delivery.

Where's Kund when you need him? Rejected by the company, rejected by the model, rejected by reality - a TOTAL reject.

We got all finished up earlier today and went to a casino for an hour or so 

SMCI ranks about #437 on S&P 500 list

by Market Cap currently...

https://stockanalysis.com/list/sp-500-stocks/

SMCI rank would move into top

270 companies in S&P 500 by Revenue

and up from #498 with Audited Financials...